providing free care to as many as 500 underserved patients across New York State
The PDCNY program will break down the barriers of geography and deliver care directly to patients who have never seen a specialist and in the comfort of their own homes.
This is so exciting! I took part in their research trial and was so impressed with its simplicity and accuracy
Vodobatinib 
Psychogenic Movement Disorders
The Fight Against Parkinson's Disease
ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)
Will Tasigna, an FDA-approved cancer drug, be the first drug to revere symptoms of Parkinson's and dementia? 
